Adoptive T Lymphocyte Administration for Chronic Norovirus Treatment in Immunocompromised Hosts
Conditions: Viral Infection; Hematopoietic Stem Cell Transplantation (HSCT); Primary Immunodeficiency Disorders (PID) Intervention: Biological: Norovirus -specific T-cell (NST) therapy Sponsor: Children's National Research Institute Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 31, 2020 Category: Research Source Type: clinical trials
Clinical Trial of Quadrivalent Recombinant Norovirus Vaccine (Pichia Pastoris)
Condition: Acute Gastroenteritis Interventions: Biological: Low-dose vaccine; Biological: High-dose vaccine; Biological: Placebo (containing aluminum); Biological: Placebo (without aluminum) Sponsor: Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - September 24, 2020 Category: Research Source Type: clinical trials